Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients
Clinical trial NCT02400281 · COMPLETED
Trial details
- NCT number
- NCT02400281
- Sponsor
- Arog Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2020-07-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.